Table 1b Clinicopathological parameters in relation to microsatellite status (n=174)

From: Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX

 

n

MSI− (no. (%))

MSI+ (no. (%))

P

Sex

 Male

76

71 (93)

5 (7)

0.29

 Female

98

87 (89)

11 (11)

 

Age, years

62

93

88 (95)

5 (5)

0.06

 > 62

81

70 (86)

11 (14)

 

T category, pathologic

 T2

18

18 (100)

0 (0)

0.38

 T3–4

156

140 (90)

16 (10)

 

N category, pathologic

 N1

99

92 (93)

7 (7)

0.27

 N2–3

75

66 (88)

9 (12)

 

Differentiation

 G1–2

125

115 (92)

10 (8)

0.38

 G3–4

49

43 (88)

6 (12)

 

Location

 Right

87

71 (82)

16 (18)

<0.0001

 Left

87

87 (100)

0 (0)

 

Treatment arm

 Arm A (5-FU/LV)

90

84 (93)

6 (7)

0.23

 Arm B (5-FU/LEV)

84

74 (88)

10 (12)

 
  1. G1, well; G2, moderately; G3, poorly; G4, anaplastic. Bold values signify P<0.05.